Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients

Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV.

Armin Steinmetz, Gerd Utermann · Journal of Biological Chemistry · 1985 · 344 citations · Full text

Lipid Analysis, Enzyme Lecithin, Human Apolipoprotein A-iv +14

Protection Against Atherogenesis in Mice Mediated by Human Apolipoprotein A-IV

Nicolas Duverger, Günter Tremp, Jean‐Michel Caillaud et al. · Science · 1996 · 254 citations

Vascular Disease, Immunology, Hyperlipidemia +18

The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine

Oliver Stein, Y. Stein, Michael Lefevre et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1986 · 243 citations

Oxysterol, Biochemistry, Lipid Rafts +10

Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.

Florian Kronenberg, Paul König, U Neyer et al. · Journal of the American Society of Nephrology · 1995 · 235 citations

Dialysis, Dialysis Therapy, Hyperlipidemia +21

Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.

R. D. Cohen, Lawrence W. Castellani, J. H. Qiao et al. · Journal of Clinical Investigation · 1997 · 169 citations · Full text

Vascular Disease, Genetics, Immunology +21